Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
October 1, 2024Journal of the Endocrine SocietyOpen Access

9189 Medullary Thyroid Cancer Due To A Novel Ret Oncogene Mutation In A Patient On Glp-1 Receptor Agonist

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKimberly LamarDJDevon JohnOFOmar Faour

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lamar et al. (2024) studied this question.

synapsesocial.com/papers/68e5611fe2b3180350efe29fhttps://doi.org/10.1210/jendso/bvae163.1999
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 112396 A Case Of Medullary Thyroid Carcinoma Without Germline RET Mutation2024
  2. 2Incidental detection of multiple endocrine neoplasia and medullary thyroid carcinoma before starting GLP-1 agonist: A case report2024 · 1 citations
  3. 38787 A Case of Indolent Medullary Thyroid Cancer with Sporadic HRAS Mutation and Prolonged Stability2024
  4. 4Germline RET variants in medullary thyroid carcinoma: A single-center experience from 2019 to 2025.2026
  5. 5CONCURRENT LYMPH NODE METASTASES OF MEDULLARY AND PAPILLARY THYROID CARCINOMA IN A CASE WITH RET PROTO-ONCOGENE GERMLINE MUTATION2024